| 2008 |
Pih1/Nop17 (yeast PIH1D1 ortholog) is an unstable protein that is stabilized by Hsp90 acting together with the Tah1 cofactor; together Tah1 and Pih1 bind the essential helicases Rvb1 and Rvb2 to form the R2TP complex, which is required for correct accumulation of box C/D snoRNPs (and also box H/ACA snoRNAs). |
Genetic interaction screens, co-immunoprecipitation, in vivo stability assays, snoRNA accumulation assays in yeast |
The Journal of cell biology |
High |
18268103
|
| 2010 |
Pih1 and Tah1 form a stable heterodimeric complex; alone Pih1 is unstable and degraded from its N terminus. The Pih1-Tah1 heterodimer binds Hsp90 with similar affinity and stoichiometry as Tah1 alone, but antagonizes Tah1's stimulatory effect and inhibits Hsp90 ATPase activity. The region within Pih1 responsible for Tah1 interaction and Hsp90 ATPase inhibition was identified. |
Analytical ultracentrifugation, isothermal titration calorimetry (ITC), noncovalent mass spectrometry, ATPase activity assay |
The Journal of biological chemistry |
High |
20663878
|
| 2011 |
NMR structure of Tah1 reveals two TPR motifs followed by a C-helix and unstructured region; Tah1 binds Hsp90 via a two-carboxylate clamp engaging the EEVD C-terminal residues of Hsp90, and binds the C terminus of Pih1 through its C-helix and unstructured region. Tah1 binding to Pih1 C terminus stabilizes Pih1 by forming a stable complex. |
NMR structure determination, binding assays, mutagenesis, in vitro/in vivo stability assays |
The Journal of biological chemistry |
High |
22179618
|
| 2012 |
The C terminus of Pih1 contains multiple destabilization/degron elements including two intrinsically disordered regions and five hydrophobic clusters; IDR2 is required for Tah1 binding. The Pih1 N-terminal domain (residues 1–230) is sufficient to bind the Rvb1/Rvb2 heterocomplex and complement Pih1 physiological function at 37°C, while the sequence between the two disordered regions significantly enhances Rvb1/Rvb2 binding. |
Site-directed mutagenesis, in vitro binding assays, in vivo complementation assays, secondary structure analysis |
The Journal of biological chemistry |
High |
23139418
|
| 2012 |
Human PIH1D1 interacts directly with histone H4 and recruits the Brg1-SWI/SNF complex (via SNF5) to rRNA gene promoters, mediates DNase I-hypersensitive chromatin remodeling at the core promoter, enhances Pol I complex occupancy and transcription initiation of rRNA genes, and displaces TIP5 (NoRC component) from the core region to derepress rRNA gene silencing. |
Co-immunoprecipitation, ChIP assays, RNAi knockdown with rRNA transcription readout, DNase I hypersensitivity assay |
Journal of molecular cell biology |
Medium |
22368283
|
| 2012 |
RPAP3 isoform 1 (but not isoform 2) interacts with PIH1D1; knockdown of RPAP3 isoform 1 reduces PIH1D1 protein level without affecting PIH1D1 mRNA, indicating post-transcriptional stabilization of PIH1D1 by RPAP3 isoform 1. |
Co-immunoprecipitation, siRNA knockdown, western blot |
Biochemical and biophysical research communications |
Medium |
23159623
|
| 2013 |
PIH1D1 specifically associates with mTORC1 (co-IP of Raptor but not Rictor); PIH1D1 knockdown decreases mTORC1 assembly, reduces S6 kinase phosphorylation (mTORC1 activity indicator), and decreases rRNA transcription without affecting mTORC2. |
Co-immunoprecipitation, siRNA knockdown, S6K phosphorylation assay, rRNA transcription assay |
FEBS letters |
Medium |
24036451
|
| 2014 |
Crystal structure of the PIH1D1 N-terminal domain (PIH-N) bound to a CK2-phosphorylated TEL2 peptide reveals a phosphopeptide-binding domain that specifically recognizes a DpSDD motif; Lys57 and Lys64 in PIH1D1 are essential for binding. Proteomic analysis identified additional R2TP substrates recruited by PIH-N in a sequence-specific, phosphorylation-dependent manner. |
Crystal structure (co-crystal with phosphopeptide), mutagenesis of Lys57/Lys64, phosphoproteomics, binding assays |
Cell reports |
High |
24656813
|
| 2014 |
Structural and biochemical analysis of Pih1D1-Tel2 complex confirms that Pih1D1 contains a domain specific for binding CK2 phosphorylation sites; structural characterization of Hsp90-Tah1-Pih1, Hsp90-Spagh (RPAP3), and Pih1D1-Tel2 complexes defines the structural basis by which the R2TP complex connects Hsp90 to the TTT complex. |
X-ray crystallography, biochemical binding assays |
Structure |
High |
24794838
|
| 2015 |
NMR solution structure of the Tah1p:Pih1p complex shows that the C-terminal tail (S93-S111) of Tah1p binds the CS domain (Pih1p264-344) forming two intermolecular β-sheets and one covering loop. Pih1p has two direct binding partners beyond Tah1p: the assembly factor Rsa1p and the snoRNP core protein Nop58p; these two interactions are mutually exclusive. Additionally, the Pih1p257-344 CS domain contacts the Hsp82 middle-C-terminal domain in the presence of Tah1p. |
NMR structure, ITC, co-expression/pulldown in E. coli, in vitro and in vivo binding assays |
Journal of molecular biology |
High |
26210662
|
| 2015 |
Nop17/Pih1 (yeast PIH1D1 ortholog) interacts with Nop58 (snoRNP core protein) and ATP modulates the interaction between Nop17 and the ATPases Rvb1/Rvb2; R2TP complex reduces affinity of Nop58 for snoRNA to facilitate binding of other snoRNP subunits. |
Co-immunoprecipitation, in vitro binding assays, domain mapping |
BMC molecular biology |
Medium |
25888478
|
| 2016 |
Pih1 is degraded via a ubiquitin-independent proteasome pathway: the proteasome subunit Rpn8 directly interacts with the Pih1 C terminus (specifically the last 30 amino acids of Rpn8 bind Pih1 C terminus); Pih1(282-344) acts as a degron sufficient to induce ubiquitin-independent degradation. Truncation of the Rpn8 C-terminal disordered region does not affect proteasome assembly but specifically inhibits degradation of GFP-Pih1(282-344) in vivo and Pih1 in vitro. |
Co-immunoprecipitation, truncation mutagenesis, in vitro and in vivo degradation assays, ubiquitin-independent proteasome assay |
The Journal of biological chemistry |
High |
27053109
|
| 2009 |
PIH1D1 stabilizes the SWI/SNF core subunit SNF5 by attenuating its proteasome-mediated degradation; overexpression of PIH1D1 increases SNF5 protein level. |
Cycloheximide chase assay, proteasome inhibitor (MG132) treatment, PIH1D1 overexpression with western blot readout |
Acta Academiae Medicinae Sinicae |
Low |
20078948
|
| 2010 |
PIH1D1 interacts with both RPAP3 and Monad (Reptin/RUVBL2) in human cells; siRNA knockdown of PIH1D1 enhances doxorubicin-induced apoptosis and caspase-3 activation, indicating PIH1D1 functions as a modulator of the apoptosis pathway. |
Co-immunoprecipitation in HEK293/U2OS cells, siRNA knockdown, caspase-3 activity assay |
Biochemical and biophysical research communications |
Medium |
21078300
|
| 2025 |
In Trypanosoma brucei, PIH1D1 concentrates at co-translational assembly sites where outer dynein arm (ODA) heavy chain (HC) translation occurs; without PIH1D1, HC protein levels are reduced and the IC-LC complex is stranded in the cytoplasm, indicating PIH1D1 generates specialized compartments to assist co-translational folding of HCs and enable their assembly with other ODA subunits. |
Live fluorescence imaging, genetic knockdown with western blot and localization readouts in Trypanosoma brucei |
bioRxivpreprint |
Low |
bio_10.1101_2025.07.26.666928
|